- greetings! Thanks so much for sharing some of your journey with us. Like Nancy, I'm interested in learning more about why you shifted away from Emgality when it was providing you with 70% success? Perhaps you were seeking more improvement? I wouldn't blame you for wanting a more comprehensive turnaround. However, I think the average success rate for CGRPs is that 30-60% of people experience a 50% improvement. Many experience less than that (or no improvement) and some have more. I took Emgality for 3 years (and yes, it IS a stingy shot!). It decreased my attack severity but didn't touch the frequency of my chronic migraine condition. I recently shifted to Qulipta and am having better success with that and it's an oral tablet so I'm enjoying skipping the injection.
At any rate, yes- I'm curious why the shift to/preference for Ajovy. Generally, Ajovy, Emgality, and Aimovig are thought to be interchangeable as they are all injectable similar forms of CGRP. There are now a lot of different variations of CGRPs out there. We often hear that people have great success with one after having failed with another (even though they are in the same family of CGRP treatments). you may be interested in this piece about why some CGRPs work and others don't: https://migraine.com/living-migraine/some-cgrps-work-others-dont.
Glad you're with us! Warmly - Holly (team member)